Unique pathologic features and gene expression signatures distinguish blastoid high-grade B-cell lymphoma from B-acute lymphoblastic leukemia/lymphoma
Haematologica
.
2023 Mar 1;108(3):895-899.
doi: 10.3324/haematol.2022.281646.
Authors
Lianqun Qiu
1
,
Jie Xu
1
,
Pei Lin
1
,
Evan N Cohen
1
,
Guilin Tang
1
,
Sa A Wang
1
,
Mahsa Khanlari
1
,
Wei Wang
1
,
Joseph D Khoury
1
,
Sergej Konoplev
1
,
C Cameron Yin
1
,
Jeffrey L Jorgensen
1
,
Francisco Vega
1
,
L Jeffrey Medeiros
1
,
Shaoying Li
2
Affiliations
1
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston.
2
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston. SLi6@mdanderson.org.
PMID:
36325892
PMCID:
PMC9973484
DOI:
10.3324/haematol.2022.281646
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Letter
MeSH terms
Humans
Lymphoma, B-Cell* / pathology
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / genetics
Transcriptome